Scope Biosciences B.V.

Scope Biosciences is a Dutch biotech company that has developed a molecular diagnostic platform, scopeDx®, which uses CRISPR-Cas technology for on-site molecular diagnostics. Their technology provides extreme accuracy, capable of detecting single nucleotide differences, and is sensitive enough to detect minute amounts of genetic material. The scopeDx® test is designed to be simple-to-use on-site with crude samples, providing results in under 25 minutes. The company focuses on applications in healthcare and agriculture.